Form 8-K - Current report:
SEC Accession No. 0001558370-25-002093
Filing Date
2025-03-04
Accepted
2025-03-04 07:00:15
Documents
47
Period of Report
2025-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pasg-20250304x8k.htm   iXBRL 8-K 38726
2 EX-99.1 pasg-20250304xex99d1.htm EX-99.1 155536
3 EX-99.2 pasg-20250304xex99d2.htm EX-99.2 46318
4 GRAPHIC pasg-20250304xex99d1001.jpg GRAPHIC 6265
5 GRAPHIC pasg-20250304xex99d2g001.jpg GRAPHIC 134321
6 GRAPHIC pasg-20250304xex99d2g002.jpg GRAPHIC 310539
7 GRAPHIC pasg-20250304xex99d2g003.jpg GRAPHIC 191776
8 GRAPHIC pasg-20250304xex99d2g004.jpg GRAPHIC 114058
9 GRAPHIC pasg-20250304xex99d2g005.jpg GRAPHIC 127183
10 GRAPHIC pasg-20250304xex99d2g006.jpg GRAPHIC 79366
11 GRAPHIC pasg-20250304xex99d2g007.jpg GRAPHIC 157634
12 GRAPHIC pasg-20250304xex99d2g008.jpg GRAPHIC 145215
13 GRAPHIC pasg-20250304xex99d2g009.jpg GRAPHIC 130401
14 GRAPHIC pasg-20250304xex99d2g010.jpg GRAPHIC 149188
15 GRAPHIC pasg-20250304xex99d2g011.jpg GRAPHIC 123731
16 GRAPHIC pasg-20250304xex99d2g012.jpg GRAPHIC 171819
17 GRAPHIC pasg-20250304xex99d2g013.jpg GRAPHIC 186401
18 GRAPHIC pasg-20250304xex99d2g014.jpg GRAPHIC 136594
19 GRAPHIC pasg-20250304xex99d2g015.jpg GRAPHIC 101550
20 GRAPHIC pasg-20250304xex99d2g016.jpg GRAPHIC 158921
21 GRAPHIC pasg-20250304xex99d2g017.jpg GRAPHIC 115818
22 GRAPHIC pasg-20250304xex99d2g018.jpg GRAPHIC 103092
23 GRAPHIC pasg-20250304xex99d2g019.jpg GRAPHIC 135974
24 GRAPHIC pasg-20250304xex99d2g020.jpg GRAPHIC 159234
25 GRAPHIC pasg-20250304xex99d2g021.jpg GRAPHIC 166072
26 GRAPHIC pasg-20250304xex99d2g022.jpg GRAPHIC 151848
27 GRAPHIC pasg-20250304xex99d2g023.jpg GRAPHIC 94730
28 GRAPHIC pasg-20250304xex99d2g024.jpg GRAPHIC 170737
29 GRAPHIC pasg-20250304xex99d2g025.jpg GRAPHIC 127691
30 GRAPHIC pasg-20250304xex99d2g026.jpg GRAPHIC 123225
31 GRAPHIC pasg-20250304xex99d2g027.jpg GRAPHIC 98148
32 GRAPHIC pasg-20250304xex99d2g028.jpg GRAPHIC 191776
33 GRAPHIC pasg-20250304xex99d2g029.jpg GRAPHIC 165485
34 GRAPHIC pasg-20250304xex99d2g030.jpg GRAPHIC 132844
35 GRAPHIC pasg-20250304xex99d2g031.jpg GRAPHIC 128429
  Complete submission text file 0001558370-25-002093.txt   6567691

Data Files

Seq Description Document Type Size
36 EX-101.SCH pasg-20250304.xsd EX-101.SCH 3273
37 EX-101.LAB pasg-20250304_lab.xml EX-101.LAB 16579
38 EX-101.PRE pasg-20250304_pre.xml EX-101.PRE 10459
49 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20250304x8k_htm.xml XML 5008
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 25701477
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)